000 01386 a2200361 4500
005 20250512040339.0
264 0 _c19880718
008 198807s 0 0 eng d
022 _a0098-1532
024 7 _a10.1002/mpo.2950160313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHurwitz, R L
245 0 0 _aReversible encephalopathy and seizures as a result of conventional vincristine administration.
_h[electronic resource]
260 _bMedical and pediatric oncology
_c1988
300 _a216-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBrain Diseases
_xchemically induced
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aFrontal Lobe
_xpathology
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphoid
_xdrug therapy
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aSeizures
_xchemically induced
650 0 4 _aTomography, X-Ray Computed
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aMahoney, D H
700 1 _aArmstrong, D L
700 1 _aBrowder, T M
773 0 _tMedical and pediatric oncology
_gvol. 16
_gno. 3
_gp. 216-9
856 4 0 _uhttps://doi.org/10.1002/mpo.2950160313
_zAvailable from publisher's website
999 _c3169879
_d3169879